Molecular predictors of lymph node metastasis in colon cancer: Increased risk with decreased thymidylate synthase expression

Journal of Gastrointestinal Surgery

Volumn 9, Issue 9, 2005, Pages 1216-1221

  Artinyan, Avo ^a   Essani, Rahila ^a   Lake, Jeffrey ^a   Kaiser, Andreas M ^a   Vukasin, Peter ^a   Danenberg, Peter ^b   Danenberg, Kathleen ^c   Haile, Robert ^a   Beart Jr , Robert W ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Response Genetics Inc   (United States)

Author keywords

Colon cancer; Lymph node metastasis; Molecular markers; Thymidylate synthase

Indexed keywords

THYMIDYLATE SYNTHASE;

COLON TUMOR; CONFERENCE PAPER; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; PATHOLOGY; RISK FACTOR;

COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RISK FACTORS; THYMIDYLATE SYNTHASE;

EID: 28644450422     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gassur.2005.06.028     Document Type: Conference Paper

References (36)

1. R.V. Hunter At last - worldwide agreement on the staging of cancer Arch Surg 122 11 1987 1235 1239
2. S. Merkel, U. Mansmann, T. Papadopoulos, C. Wittekind, W. Hohenberger, and P. Hermanek The prognostic inhomogeneity of colorectal carcinomas stage III Cancer 92 2001 2754 2759
3. G.J. Liefers, A.M. Cleton-Jansen, and C.J.H. Van de Velde Micrometastases and survival in stage II colorectal cancer N Engl J Med 339 1998 223 228
4. J. Jen, H. Kim, and S. Piantadosi Allelic loss of chromosome 18q and prognosis in colorectal cancer N Engl J Med 331 4 1995 213 221
5. P. Laurent-Puig, S. Olschwang, and O. Delattre Survival and acquired genetic alterations in colorectal cancer Gastroenterology 102 1992 1136 1141
6. R. Gryfe, H. Kim, and E.T. Hsieh Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer N Engl J Med 342 2 2000 69 77
7. R.V. Lord, D. Salonga, and K.D. Danenberg Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence J Gastrointest Surg 4 2 2000 135 142
8. C.C. Compton, L.P. Fielding, and L.J. Burgart Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999 Arch Pathol Lab Med 124 7 2000 979 994
9. M.V. Agrez, D. Spagnolo, J. Harve, A.K. House, and D. O'Connell Prognostic significance of lymphatic permeation in Dukes' B colorectal cancer Aust N Z J Surg 58 1 1988 39 42
10. S. Fujita, T. Shimoda, K. Yoshimura, S. Yamamoto, T. Akasu, and Y. Moriya Prospective evaluation of prognostic factors in patients with colorectal cancer undergoing curative resection J Surg Oncol 84 3 2003 127 131
11. F.T. Bosman Prognostic value of pathological characteristics of colorectal cancer Eur J Cancer 31A 7-8 1995 1216 1221
12. P.V. Danenberg, H. Malli, and S. Swenson Thymidylate synthase inhibitors Semin Oncol 26 1999 621 631
13. P.G. Johnston, H.J. Lenz, and C.G. Leichman Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors Cancer Res 55 1995 1407 1412
14. T. Yamachika, H. Nakanishi, and K. Inada A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significance Cancer 82 1 1998 70 77
15. M. Kornmann, K.H. Link, and H.J. Lenz Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy Cancer Lett 118 1 1997 29 35
16. H.J. Lenz, K.D. Danenberg, and C.G. Leichman p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site Clin Cancer Res 4 5 1998 1227 1234
17. A. Hosokawa, Y. Yamada, and Y. Shimada Prognostic significance of thymidylate synthase in patients with metastatic colorectal cancer who receive protracted venous infusions of 5-fluorouracil Int J Clin Oncol 9 5 2004 388 392
18. M.E. Fernandez-Contreras, B. Jimenez De Ayala, and M.L. Garcia De Paredes Thymidylate synthase expression pattern is a prognostic factor in patients of colorectal cancer treated with 5-fluorouracil Int J Oncol 25 4 2004 877 885
19. R. Sanguedolce, G. Vultaggio, and F. Sanguedolce The role of thymidylate synthase levels in the prognosis and the treatment of patients with colorectal cancer Anticancer Res 18 3A 1998 1515 1520
20. D. Ofner, K. Riehemann, and H. Maier Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumour stage and patient survival Br J Cancer 72 4 1995 981 985
21. F.A. Sinicrope, J. Hart, F. Michelassi, and J.J. Lee Prognostic value of Bcl-2 oncoprotein expression in stage II colon carcinoma Clin Cancer Res 1 1995 1103 1110
22. U. Manne, H.L. Weiss, and W.E. Grizzle Bcl-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas Int J Cancer 89 2000 423 430
23. T. Yamauchi, M. Watanabe, and T. Kubota Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer Dis Colon Rectum 45 1 2002 98 103
24. J. Li, H. Miki, M. Ohmori, F. Wu, and Y. Runamoto Expression of cyclin E and cyclin-dependent kinase 2 correlates with metastasis and prognosis in colorectal carcinoma Hum Pathol 32 9 2001 945 953
25. Y. Shirota, W. Ichikawa, H. Uetake, H. Yamada, Z. Nihei, and K. Sugihara Intratumoral dihydropyrimidine dehydrogenase messenger RNA level reflects tumor progression in human colorectal cancer Ann Surg Oncol 9 6 2002 599 603
26. M.B. Resnick, J. Routhier, T. Konkin, E. Sabo, and V.E. Pricolo Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: a tissue microarray study Clin Cancer Res 10 9 2004 3069 3075
27. R.S. Weinstein, S.M. Jakate, and J.M. Dominguez Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis Cancer Res 51 10 1991 2720 2726
28. S.C. Linn, and G. Giaccone MDR1/P-glycoprotein expression in colorectal cancer Eur J Cancer 31A 1995 1291 1294
29. Z.S. Zeng, and J.G. Guillem Unique activation of matrix- metalloproteinase-9 within human liver metastasis from colorectal cancer Br J Cancer 78 3 1998 349 353
30. Y. Matsuyama, S. Takao, and T. Aikou Comparison of matrix- metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas J Surg Oncol 80 2 2002 105 110
31. D.F. Liu, K. Ferguson, G.S. Cooper, W.M. Grady, and J. Willis p27 cell-cycle inhibitor is inversely correlated with lymph node metastases in right sided colon cancer J Clin Lab Anal 13 1999 291 295
32. kip1 protein expression and spontaneous apoptosis in patients with colorectal adenocarcinomas Oncology 58 2000 45 51
33. N. Minagawa, Y. Nakayama, and K. Hirata Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer Anticancer Res 22 5 2002 2957 2963
34. T. Nakasaki, H. Wada, and C. Shigemori Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer Am J Hematol 69 4 2002 247 254
35. Y. Tokunaga, H. Hosogi, T. Hoppou, M. Nakagami, A. Tokuka, and K. Ohsumi Prognostic value of thymidine phosphorylase/platelet-derived endothelial cell growth factor in advanced colorectal cancer after surgery: evaluation with a new monoclonal antibody Surgery 131 5 2002 541 547
36. C.M. Wright, O.F. Dent, and M. Barker Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer Br J Surg 87 9 2000 1197 1202